Cover Image
市場調查報告書

冠狀動脈硬化症:全球臨床實驗檢討

Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 310945
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈硬化症:全球臨床實驗檢討 Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014
出版日期: 2014年08月20日 內容資訊: 英文 83 Pages
簡介

本報告提供冠狀動脈硬化症相關臨床研究之最新趨勢相關分析,為您彙整疾病·治療方法概要,及G7各國與E7(新興7國)的臨床實驗狀況,地區、Phase、階段別進行狀況,有潛力的贊助商,再加上各企業及研究機關的研究進行狀況,及有潛力的藥劑比較等資訊。

簡介

  • 冠狀動脈硬化症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 冠狀動脈硬化症臨床實驗數量中,心臟血管臨床實驗數量所佔的比例

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 冠狀動脈硬化症臨床實驗數量中,心臟血管臨床實驗數量所佔的比例

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗冠狀動脈硬化症

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 冠狀動脈硬化症治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • Cytori Therapeutics, Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • AstraZeneca PLC
    • MDDX LLC
    • Innovaderm Research Inc.
    • CardioVascular BioTherapeutics, Inc.
    • Avant Immunotherapeutics, Inc
  • 有代表性的研究機關醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • Providence VA Medical Center
    • National Taiwan University Hospital
    • Seoul National University Hospital
    • Rigshospitalet
    • University of Ottawa Heart Institute
    • University of California, San Diego
    • University of Minnesota
    • Massachusetts General Hospital
    • U.S. Department of Veterans Affairs

5大臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2306CTIDB

GlobalData's clinical trial report, "Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Arteriosclerosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Coronary Arteriosclerosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Coronary Arteriosclerosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Coronary Arteriosclerosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Cytori Therapeutics, Inc.
      • Clinical Trial Overview of Cytori Therapeutics, Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • MDDX LLC
      • Clinical Trial Overview of MDDX LLC
      • Innovaderm Research Inc.
      • Clinical Trial Overview of Innovaderm Research Inc.
      • CardioVascular BioTherapeutics, Inc.
      • Clinical Trial Overview of CardioVascular BioTherapeutics, Inc.
      • Avant Immunotherapeutics, Inc
      • Clinical Trial Overview of Avant Immunotherapeutics, Inc
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Providence VA Medical Center
      • Clinical Trial Overview of Providence VA Medical Center
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • University of Ottawa Heart Institute
      • Clinical Trial Overview of University of Ottawa Heart Institute
      • University of California, San Diego
      • Clinical Trial Overview of University of California, San Diego
      • University of Minnesota
      • Clinical Trial Overview of University of Minnesota
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by MDDX LLC, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioVascular BioTherapeutics, Inc., 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Avant Immunotherapeutics, Inc, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Providence VA Medical Center, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*

List of Figures

  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top